Literature DB >> 1112981

Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.

U R Nilsson, R J Mandle, J A McConnell-Mapes.   

Abstract

The subunit composition of human C3 and C5 was analyzed. Acrylamide gel electrophoresis of the fully reduced and dissociated proteins disclosed a similar structure, consisting of one alpha and beta subunit, linked together by one or more disulfide bonds. The approximate molecular weights for the alpha and beta subunits of C3 as well as C5 were 140,000 and 80,000 respectively. C42 caused cleavage solely of C3alpha, whereas trypsin affected both C3alpha as well as C3beta. A characteristic subunit modification by both enzmes indicated that C3alpha constitutes the source of C3a. C423 as well as trypsin exclusively affect C5alpha. C5a therefore appears to originate from the C5alpha subunit. The mode of primary cleavage by C423 and trypsin differs, giving rise to different forms of C5b. The questions is raised if multiple forms of C5a also exist. It appeared from our studies that certain forms of C5b may retain portions of the alpha subunit, which could potentially release some biologically active split products following secondary cleavage by the appropriate enzyme.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1112981

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.

Authors:  C H Hammer; A Nicholson; M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Evidence for a two-domain structure of the terminal membrane C5b-9 complex of human complement.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.

Authors:  J G Sissons; J Liebowitch; N Amos; D K Peters
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

Review 4.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Inflammatory mediators released by complement-derived peptides.

Authors:  H Bult; A G Herman
Journal:  Agents Actions       Date:  1983-08

6.  Covalent binding and hemolytic activity of complement proteins.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

7.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

8.  Non-enzymic activation of the covalent binding reaction of the complement protein C3.

Authors:  S K Law
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

9.  Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.

Authors:  B Nilsson; D Grossberger; K Nilsson Ekdahl; P Riegert; D J Becherer; U R Nilsson; J D Lambris
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

10.  Amino acid sequence of the trypsin-generated C3d fragment from human complement factor C3.

Authors:  U Hellman; G Eggertsen; A Engström; J Sjöquist
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.